Valeritas Holdings, Inc. (VLRXQ)
OTOTC · Common · CUSIP 91914N301
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VLRXQ and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
91914N301 (prev. 91914N202 )
Market Cap
Micro Cap · $0 Million
Previous Symbol
VLRX (changed 3/10/2020)
Business: Valeritas Holdings, Inc. is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies.
Notes: February 9, 2020 -- Valeritas Holdings, Inc. (NASDAQ: VLRX) (“Valeritas” or the “Company”), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, today announced an agreement to sell substantially all of the business to Zealand Pharma A/S (NASDAQ: ZEAL) (“Zealand”), a Denmark-based biotechnology company.

Company Contact

CEO
John Timberlake
CFO
Erick Lucera
Headquarters
750 Route 202 South, Suite 600, Bridgewater, NJ 08807
Phone
908-927-9920
Investor Relations
Nick Laudico, The Ruth Group · 646-536-7030 · IR@valeritas.com
SEC EDGAR Filings
View filings »